SOX2 is required to maintain cancer stem cells in ovarian cancer.
about
Correlation of Cancer Stem-Cell Markers OCT4, SOX2, and NANOG with Clinicopathological Features and Prognosis in Operative Patients with Rectal Cancer.Ovarian Cancers: Genetic Abnormalities, Tumor Heterogeneity and Progression, Clonal Evolution and Cancer Stem Cells.XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.Application of induced pluripotency in cancer studies.Are ovarian cancer stem cells the target for innovative immunotherapy?Immune Curbing of Cancer Stem Cells by CTLs Directed to NANOG.
P2860
SOX2 is required to maintain cancer stem cells in ovarian cancer.
description
2017 nî lūn-bûn
@nan
2017 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
SOX2 is required to maintain cancer stem cells in ovarian cancer.
@ast
SOX2 is required to maintain cancer stem cells in ovarian cancer.
@en
type
label
SOX2 is required to maintain cancer stem cells in ovarian cancer.
@ast
SOX2 is required to maintain cancer stem cells in ovarian cancer.
@en
prefLabel
SOX2 is required to maintain cancer stem cells in ovarian cancer.
@ast
SOX2 is required to maintain cancer stem cells in ovarian cancer.
@en
P2093
P2860
P356
P1433
P1476
SOX2 is required to maintain cancer stem cells in ovarian cancer
@en
P2093
P2860
P304
P356
10.1111/CAS.13186
P50
P577
2017-04-01T00:00:00Z